Three levels of service—Silver, Gold and Platinum—are rolling out globally
Intent on capturing as much of the burgeoning field of healthcare shipping, including clinical trial logistics, as it can, UPS Healthcare Logistics has announced expansions of its existing Silver and Gold services, in addition to a new Platinum service. The latter capability, to become operational in the fall in the US, includes use of mesh technology (a way of creating a dedicated wireless network) to communicate temperature, location and environmental conditions of small-package deliveries in real time both within and without the UPS physical network.
UPS Healthcare Logistics announced its Premier Gold service in 2020 in the US; since then it has been expanded to Canada and Europe, and Mexico and Asia-Pacific locations are about to go live. The Silver service, based on lower-cost RFID sensors, has also expanded and will continue to be rolled out globally. Premier Gold will launch next January in India, says the company. What UPS calls “controlled product protection” includes 24/7 monitoring of shipments and the ability to intervene to recharge refrigerants, redirect shipments or otherwise recover a shipment.
“Our involvement in Operation Warp Speed to transport Covid-19 vaccines globally served to accelerate our service enhancements,” says Wes Wheeler, president of UPS Healthcare Logistics. “As of today, we’re involved one way or another with the commercial deliveries of 5 of the approved ten cellular and genetic technologies—a field that will be transformational for biopharma.” Wheeler adds that in the next 2 to 5 years, UPS Healthcare Logistics more-then 10 million sq. ft. of global warehousing capacity will expand by another 4 million.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.